[VIEW] agent=Finance Allowance & Reporting Manager | scenario_id=30 | rounds=20

--- Round 0 ---
[R0.1] Credit Risk Modeling Lead (speak, public): To support our Q1 2026 Allowance Committee decision, I'm looking for some key information. Can we start with the current reserve baseline and any internal approval thresholds for discretionary adjustments? Also, I'd appreciate an overview of the portfolio's size, composition, and any notable concentrations.
[R0.2] Commercial Real Estate Portfolio Director (speak, public): I can provide some context about our commercial real estate portfolio. We have a total outstanding balance of $9.6 billion with an average LTV of 62%. Our segment mix is predominantly multifamily at 34% and office at 28%. Looking ahead to the next 60 days, we're pausing office originations while we have a $310M pipeline. I'd be happy to discuss how these factors might influence our allowance approach.
[R0.3] Finance Allowance & Reporting Manager (speak, public): I've shared the current ACL position for CRE, which is $312M with a coverage ratio of 3.25%. To support our Q1 2026 Allowance Committee decision, I need to understand the governance milestones for the updated CRE expected-credit-loss methodology and evidence that it performs acceptably in our riskiest segments. Can you provide an update on these aspects?

--- Round 1 ---
[R1.1] Credit Risk Modeling Lead (speak, public): We've made good progress. To recap, we have a $9.6 billion CRE portfolio with significant multifamily and office segments. Our current ACL is $312M with a 3.25% coverage ratio. I've shared our macro scenario design and backtest accuracy. To finalize our recommendation, I still need to understand the internal approval thresholds for discretionary adjustments and any concerns about single-name concentrations or capital headroom. Can we discuss these aspects?
[R1.2] Commercial Real Estate Portfolio Director (speak, public): To address the remaining questions, I'd like to share that we've been using fairly conservative assumptions in our modeling, particularly for office and multifamily segments. Our stress testing indicates that the model performs reasonably well even under adverse scenarios. Regarding external reporting, we're on track to meet our disclosure deadlines, with final portfolio narratives due around the 15th of February. On model governance, while there are some concerns about backtesting accuracy in certain segments, we're working on refining our approach. As for finance's perspective, I'm not aware of any unusually tight earnings or capital constraints that would influence our decision, but I can check with our finance team to confirm.
[R1.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 2 ---
[R2.1] Credit Risk Modeling Lead (speak, public): To finalize our recommendation for the Q1 2026 Allowance Committee, I still need to understand the internal approval thresholds for discretionary adjustments and confirm if there are any outsized single-name concentrations or tight capital headroom. Can we discuss these aspects further, particularly from a finance perspective?
[R2.2] Commercial Real Estate Portfolio Director (speak, public): I understand the need to discuss internal approval thresholds and potential single-name concentrations. I've checked with our finance team regarding earnings and capital constraints, and they haven't indicated any unusual tightness that would impact our decision for the Q1 2026 Allowance Committee. However, to be certain about the approval thresholds, I'll need to confirm with them directly as this isn't information I typically handle. I'll follow up with our finance team to get a clearer picture on both the capital situation and the internal thresholds for discretionary adjustments.
[R2.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 3 ---
[R3.1] Credit Risk Modeling Lead (speak, public): I appreciate your efforts to check with the finance team regarding internal approval thresholds and capital constraints. To move forward, could you also confirm if there are any outsized single-name concentrations in our CRE portfolio that we should be aware of? This information is crucial for finalizing our recommendation for the Q1 2026 Allowance Committee.
[R3.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 4 ---
[R4.1] Credit Risk Modeling Lead (speak, public): Thank you for sharing the sensitive information about our largest borrower exposure and top 10 exposures. This helps me understand the concentration risk in our CRE portfolio. I'm still waiting to hear back on the internal approval thresholds for discretionary adjustments from the finance team. Could you please follow up on that?
[R4.2] Commercial Real Estate Portfolio Director (speak, public): I've followed up with our finance team regarding the internal approval thresholds for discretionary adjustments. They're confirming the specific thresholds and will get back to me shortly. I'll share the information as soon as I receive it.
[R4.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 5 ---
[R5.1] Credit Risk Modeling Lead (speak, public): I appreciate your follow-up with the finance team regarding the internal approval thresholds for discretionary adjustments. Once we have this information, I'll be able to finalize our recommendation for the Q1 2026 Allowance Committee. Please let me know as soon as you receive an update from them.
[R5.2] Commercial Real Estate Portfolio Director (leave, public): 
[R5.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 6 ---
[R6.1] Credit Risk Modeling Lead (leave, public): 
[R6.2] Commercial Real Estate Portfolio Director (leave, public): 
[R6.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 7 ---
[R7.1] Credit Risk Modeling Lead (leave, public): 
[R7.2] Commercial Real Estate Portfolio Director (leave, public): 
[R7.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 8 ---
[R8.1] Credit Risk Modeling Lead (leave, public): 
[R8.2] Commercial Real Estate Portfolio Director (leave, public): 
[R8.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 9 ---
[R9.1] Credit Risk Modeling Lead (leave, public): 
[R9.2] Commercial Real Estate Portfolio Director (leave, public): 
[R9.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 10 ---
[R10.1] Credit Risk Modeling Lead (leave, public): 
[R10.2] Commercial Real Estate Portfolio Director (leave, public): 
[R10.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 11 ---
[R11.1] Credit Risk Modeling Lead (leave, public): 
[R11.2] Commercial Real Estate Portfolio Director (leave, public): 
[R11.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 12 ---
[R12.1] Credit Risk Modeling Lead (leave, public): 
[R12.2] Commercial Real Estate Portfolio Director (leave, public): 
[R12.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 13 ---
[R13.1] Credit Risk Modeling Lead (leave, public): 
[R13.2] Commercial Real Estate Portfolio Director (leave, public): 
[R13.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 14 ---
[R14.1] Credit Risk Modeling Lead (leave, public): 
[R14.2] Commercial Real Estate Portfolio Director (leave, public): 
[R14.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 15 ---
[R15.1] Credit Risk Modeling Lead (leave, public): 
[R15.2] Commercial Real Estate Portfolio Director (leave, public): 
[R15.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 16 ---
[R16.1] Credit Risk Modeling Lead (leave, public): 
[R16.2] Commercial Real Estate Portfolio Director (leave, public): 
[R16.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 17 ---
[R17.1] Credit Risk Modeling Lead (leave, public): 
[R17.2] Commercial Real Estate Portfolio Director (leave, public): 
[R17.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 18 ---
[R18.1] Credit Risk Modeling Lead (leave, public): 
[R18.2] Commercial Real Estate Portfolio Director (leave, public): 
[R18.3] Finance Allowance & Reporting Manager (leave, public): 

--- Round 19 ---
[R19.1] Credit Risk Modeling Lead (leave, public): 
[R19.2] Commercial Real Estate Portfolio Director (leave, public): 
[R19.3] Finance Allowance & Reporting Manager (leave, public): 

